Logo image of SORA

ASIASTRATEGY (SORA) Stock Fundamental Analysis

USA - NASDAQ:SORA - KYG8946B1086 - Common Stock

5.42 USD
-0.02 (-0.37%)
Last: 10/22/2025, 8:03:23 PM
5.24 USD
-0.18 (-3.32%)
After Hours: 10/22/2025, 8:03:23 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SORA. SORA was compared to 22 industry peers in the Distributors industry. The financial health of SORA is average, but there are quite some concerns on its profitability. SORA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SORA had negative earnings in the past year.
SORA had a negative operating cash flow in the past year.
SORA Yearly Net Income VS EBIT VS OCF VS FCFSORA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

SORA has a Return On Assets (-0.64%) which is comparable to the rest of the industry.
The Return On Equity of SORA (-3.07%) is worse than 63.64% of its industry peers.
SORA has a Return On Invested Capital of 3.92%. This is comparable to the rest of the industry: SORA outperforms 50.00% of its industry peers.
SORA had an Average Return On Invested Capital over the past 3 years of 8.05%. This is significantly below the industry average of 14.75%.
The 3 year average ROIC (8.05%) for SORA is well above the current ROIC(3.92%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.64%
ROE -3.07%
ROIC 3.92%
ROA(3y)1.37%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.05%
ROIC(5y)N/A
SORA Yearly ROA, ROE, ROICSORA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

The Operating Margin of SORA (1.30%) is comparable to the rest of the industry.
SORA has a worse Gross Margin (8.04%) than 68.18% of its industry peers.
Industry RankSector Rank
OM 1.3%
PM (TTM) N/A
GM 8.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SORA Yearly Profit, Operating, Gross MarginsSORA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 2 4 6 8

More info and screens

5

2. Health

2.1 Basic Checks

SORA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SORA has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for SORA has been reduced compared to a year ago.
SORA Yearly Shares OutstandingSORA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
SORA Yearly Total Debt VS Total AssetsSORA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M

2.2 Solvency

SORA has an Altman-Z score of 18.77. This indicates that SORA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 18.77, SORA belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
A Debt/Equity ratio of 2.35 is on the high side and indicates that SORA has dependencies on debt financing.
The Debt to Equity ratio of SORA (2.35) is worse than 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.35
Debt/FCF N/A
Altman-Z 18.77
ROIC/WACC0.39
WACC10.17%
SORA Yearly LT Debt VS Equity VS FCFSORA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M -1M 2M -2M 3M

2.3 Liquidity

A Current Ratio of 2.87 indicates that SORA has no problem at all paying its short term obligations.
SORA's Current ratio of 2.87 is amongst the best of the industry. SORA outperforms 81.82% of its industry peers.
SORA has a Quick Ratio of 1.80. This is a normal value and indicates that SORA is financially healthy and should not expect problems in meeting its short term obligations.
SORA's Quick ratio of 1.80 is fine compared to the rest of the industry. SORA outperforms 77.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.87
Quick Ratio 1.8
SORA Yearly Current Assets VS Current LiabilitesSORA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for SORA have decreased strongly by -121.52% in the last year.
Looking at the last year, SORA shows a decrease in Revenue. The Revenue has decreased by -6.35% in the last year.
EPS 1Y (TTM)-121.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.52%
Revenue 1Y (TTM)-6.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SORA Yearly Revenue VS EstimatesSORA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
SORA Price Earnings VS Forward Price EarningsSORA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SORA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 600.07
SORA Per share dataSORA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SORA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASIASTRATEGY

NASDAQ:SORA (10/22/2025, 8:03:23 PM)

After market: 5.24 -0.18 (-3.32%)

5.42

-0.02 (-0.37%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap134.74M
Revenue(TTM)17.62M
Net Income(TTM)-42200
AnalystsN/A
Price TargetN/A
Short Float %0.28%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 7.65
P/FCF N/A
P/OCF N/A
P/B 98.12
P/tB 98.12
EV/EBITDA 600.07
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.71
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.64%
ROE -3.07%
ROCE 4.97%
ROIC 3.92%
ROICexc 9.21%
ROICexgc 9.21%
OM 1.3%
PM (TTM) N/A
GM 8.04%
FCFM N/A
ROA(3y)1.37%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.05%
ROIC(5y)N/A
ROICexc(3y)13.8%
ROICexc(5y)N/A
ROICexgc(3y)13.8%
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.66
Health
Industry RankSector Rank
Debt/Equity 2.35
Debt/FCF N/A
Debt/EBITDA 14.05
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.81
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.87
Quick Ratio 1.8
Altman-Z 18.77
F-Score3
WACC10.17%
ROIC/WACC0.39
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-121.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-121.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-56.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-134.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-134.05%
OCF growth 3YN/A
OCF growth 5YN/A